Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SUTIMLIMAB-JOME Cause Inappropriate schedule of product administration? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Inappropriate schedule of product administration have been filed in association with SUTIMLIMAB-JOME. This represents 3.8% of all adverse event reports for SUTIMLIMAB-JOME.

8
Reports of Inappropriate schedule of product administration with SUTIMLIMAB-JOME
3.8%
of all SUTIMLIMAB-JOME reports
0
Deaths
0
Hospitalizations

How Dangerous Is Inappropriate schedule of product administration From SUTIMLIMAB-JOME?

Of the 8 reports.

Is Inappropriate schedule of product administration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SUTIMLIMAB-JOME. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does SUTIMLIMAB-JOME Cause?

Off label use (18) Arthralgia (15) Haemoglobin decreased (15) Condition aggravated (12) Drug ineffective (10) Fatigue (10) Haemolysis (10) Headache (9) Covid-19 (7) Cyanosis (7)

What Other Drugs Cause Inappropriate schedule of product administration?

ADAPALENE (16,473) DUPILUMAB (14,927) AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546) INSULIN GLARGINE (8,982) INFLIXIMAB (6,847) INFLIXIMAB-DYYB (5,977) SECUKINUMAB (4,817) DULAGLUTIDE (3,606) VEDOLIZUMAB (3,259) SACUBITRIL\VALSARTAN (2,870)

Which SUTIMLIMAB-JOME Alternatives Have Lower Inappropriate schedule of product administration Risk?

SUTIMLIMAB-JOME vs SUVOREXANT SUTIMLIMAB-JOME vs SUZETRIGINE SUTIMLIMAB-JOME vs SYMBICORT SUTIMLIMAB-JOME vs SYNAGIS SUTIMLIMAB-JOME vs SYNTHROID

Related Pages

SUTIMLIMAB-JOME Full Profile All Inappropriate schedule of product administration Reports All Drugs Causing Inappropriate schedule of product administration SUTIMLIMAB-JOME Demographics